Ajanta Pharma Peer Comparison

NSE: AJANTPHARM | BSE: 532331

₹3,508.80

₹49.10 (1.42%)

As on 30-Oct-2026IST

Market cap

₹43,891 Cr

Revenue (TTM)

₹6,217 Cr

P/E Ratio

34.8

P/B Ratio

Div. Yield

0.8 %

Edit

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
Market cap (₹ Cr)	43,891	1,12,699	1,02,797	4,26,662	1,76,306
Revenue (₹ Cr)	6,217	33,097	15,379	61,631	17,400
Net Profit (₹ Cr)	1,262.83	2,759.70	2,249.69	11,037.19	2,099.00
Net Margin (%)	19.70	8.03	14.32	17.23	12.10
RoE (%)	26.91	7.30	13.86	14.23	16.47
Price to Earnings	34.76	40.25	45.84	38.91	83.01
Price-To-Book	9.03	2.90	5.85	4.78	9.60

Income Statement (₹ Cr)

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
Operating Revenue	6,216.60	33,097.40	15,378.58	61,630.92	17,400.00
Total Income	6,411.29	34,352.50	15,705.47	64,063.12	17,348.00
Total Expenditure	4,529.81	28,236.90	11,301.83	43,720.59	11,626.00
EBITDA	1,686.79	4,860.50	4,076.75	17,910.33	5,774.00
Depreciation	180.94	2,141.40	907.11	3,004.86	1,916.00
EBIT	1,505.85	2,719.10	3,169.64	14,905.47	3,858.00
Interest	12.88	450.40	513.87	338.59	886.00
Other Income	194.69	1,255.10	326.89	2,432.20	-52.00
Exceptional Items	0.00	0.00	-129.75	-1,962.40	-107.00
Profit before Tax	1,687.66	3,523.80	2,852.91	15,036.68	2,813.00
Provision for Tax	424.83	764.10	603.22	3,999.49	714.00
Profit after Tax	1,262.83	2,759.70	2,249.69	11,037.19	2,099.00

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
Shareholder's Funds	4,858.27	38,807.00	17,582.22	89,279.88	18,373.00
Minority Interest	0.00	40.20	-20.87	-20.97	25.00
Non-Current Liabilities	224.20	3,074.90	5,214.33	1,683.12	18,258.00
Current Liabilities	1,342.80	15,430.30	5,884.79	23,591.58	7,984.00
Total Liabilities	6,317.22	56,576.70	27,754.83	1,08,407.20	43,613.69

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
Non-Current Assets	2,373.25	26,891.10	20,096.89	44,135.45	33,165.00
Current Assets	3,823.28	29,732.20	7,956.27	69,266.58	10,517.00
Total Assets	6,317.22	56,576.70	27,754.83	1,08,407.20	43,613.69
Total Debt*	211.99	7,734.10	6,021.78	4,081.61	14,798.24
Net Current Assets	2,480.48	14,301.90	2,071.48	45,675.00	2,533.00
Contingent Liabilities	8.12	336.14	924.77	1,587.05	379.25

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
Cash From Operating Activities	529.19	5,673.70	3,121.29	12,419.18	3,022.71
Cash Flow from Investing Activities	-428.92	-6,549.30	-196.42	-11,344.05	-12,712.41
Cash from Financing Activities	-167.92	829.00	-2,952.69	-2,512.55	10,150.60
Net Cash Inflow / Outflow	-67.65	-46.60	-27.82	-1,437.42	460.90

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
ROCE (%)	32.67	13.75	13.24	19.11	19.27
ROE (%)	26.91	7.30	13.86	14.23	16.47
ROA (%)	20.88	4.93	7.79	10.10	6.98
EBIT Margin (%)	24.22	8.22	20.61	24.19	22.17
Net Margin (%)	19.70	8.03	14.32	17.23	12.10
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
Revenue Growth (%)	25.01	-3.53	13.53	12.13	42.06
EBIT Growth (%)	32.42	-58.47	31.59	7.78	21.02
Net Profit Growth (%)	29.70	-51.77	27.79	4.94	-1.92
EPS Growth (%)	29.67	-51.50	34.22	6.57	-1.09
Book Value Growth (%)	19.52	12.99	13.74	15.72	10.51

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
Price / Earnings	34.75	40.25	43.76	34.69	73.16
Price / Book Value	9.03	2.90	5.85	4.78	9.60
Dividend Yield (%)	0.80	0.59	0.04	0.90	0.82
EV/EBITDA	25.75	23.33	26.20	22.23	32.75
Market Cap (₹ Cr)	35,015.54	1,04,763.81	82,801.75	4,21,639.92	1,42,851.87

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
Debt to Equity	0.00	0.00	0.17	0.00	0.63
Short term debt to equity ratio	0.05	0.16	0.04	0.05	0.35
Current Ratio	2.85	1.93	1.35	2.94	1.32
Quick Ratio	2.13	1.40	0.95	2.40	0.92
Interest Coverage	132.03	8.82	6.55	45.41	4.17

	Ajanta Pharma	Dr. Reddy'S Labs	Mankind Pharma	Sun Pharmaceutical	Torrent Pharma
Debtors to sales (%)	29.98	30.64	14.17	28.89	19.53
Asset Turnover	1.03	0.59	0.53	0.56	0.58
Receivable days	49.07	103.79	39.93	89.14	45.41
Inventory Days	29.77	79.94	51.78	67.85	52.67
Payable days	183.00	84.78	111.46	213.72	244.06
Cash Conversion Cycle	-104.16	98.95	-19.75	-56.72	-145.98

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.